Literature DB >> 18775885

Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles.

Weon-Young Son1, Jin-Tae Chung, Belen Herrero, Nicola Dean, Ezgi Demirtas, Hananel Holzer, Shai Elizur, Ri-Cheng Chian, Seang Lin Tan.   

Abstract

BACKGROUND: The efficiency of in vitro maturation (IVM) techniques is suboptimal compared with controlled ovarian stimulation combined with IVF cycles, and studies are needed to identify factors that predispose IVM cycles to success or failure. We compared the outcome of IVM cycles with different dominant follicle (DF) size at oocyte retrieval following hCG priming.
METHODS: IVM was performed in 160 patients with polycystic ovaries (171 cycles). We administered 10,000 IU hCG s.c. 35-38 h before oocyte collection when endometrial thickness reached at least 6 mm. IVM cycles were retrospectively analyzed according to DF diameter as follows; Group 1: DF diameter <or=10 mm, Group 2: between 10 and 14 mm, Group 3: >14 mm. RESULTS A positive correlation was observed between DF size and number of in vivo matured oocytes collected (Group 1, 2 and 3 = 6.9, 10.6 and 15.1%, respectively). The rates of IVM, fertilization and embryo development were similar among the sibling immature oocytes collected from the three groups. However, clinical pregnancy rate in Group 2 (40.3%) was higher than Group 3 (17.1%) (P < 0.05). Moreover, implantation rates in Groups 1 (13.6%) and 2 (14.3%) were higher than Group 3 (4.9%) (P < 0.01).
CONCLUSIONS: Our results suggest that oocyte collection in IVM cycles should be performed when the DF is 14 mm diameter or less. Sibling immature oocytes may be affected detrimentally if a DF >14 mm is present at oocyte collection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775885     DOI: 10.1093/humrep/den332

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  21 in total

1.  Comparison of fertilization and embryonic development in sibling in vivo matured oocytes retrieved from different sizes follicles from in vitro maturation cycles.

Authors:  Weon-Young Son; Jin-Tae Chung; Michael Dahan; Shauna Reinblatt; Seang Lin Tan; Hananel Holzer
Journal:  J Assist Reprod Genet       Date:  2010-12-29       Impact factor: 3.412

2.  Mosaic embryo transfer after oocyte in vitro maturation in combination with non-invasive prenatal testing (NIPT)-first report of a euploid live birth.

Authors:  Naomi Inoue; Rosmary Lopez; Andrea Delgado; Denisse Nuñez; Jimmy Portella; Luis Noriega-Hoces; Luis Guzmán
Journal:  J Assist Reprod Genet       Date:  2017-06-24       Impact factor: 3.412

Review 3.  What is the optimal condition for fertilization of IVM oocytes?

Authors:  Hiroaki Funahashi
Journal:  Reprod Med Biol       Date:  2012-08-10

4.  In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe.

Authors:  Ingrid Segers; Ileana Mateizel; Ellen Van Moer; Johan Smitz; Herman Tournaye; Greta Verheyen; Michel De Vos
Journal:  J Assist Reprod Genet       Date:  2015-08-08       Impact factor: 3.412

5.  Spontaneous in vitro maturation of oocytes prior to ovarian tissue cryopreservation in natural cycles of oncologic patients.

Authors:  María-José Escribá; Noelia Grau; Laura Escrich; Edurne Novella-Maestre; María Sánchez-Serrano
Journal:  J Assist Reprod Genet       Date:  2012-09-11       Impact factor: 3.412

6.  Fertility preservation for young women with rectal cancer--a combined approach from one referral center.

Authors:  Shai E Elizur; Togas Tulandi; Sarkis Meterissian; Jack Y J Huang; Dan Levin; Seang Lin Tan
Journal:  J Gastrointest Surg       Date:  2009-02-18       Impact factor: 3.452

7.  Fertilization, embryo development, and clinical outcome of immature oocytes obtained from natural cycle in vitro fertilization.

Authors:  Weon-Young Son; Jin-Tae Chung; Mausumi Das; William Buckett; Ezgi Demirtas; Hananel Holzer
Journal:  J Assist Reprod Genet       Date:  2012-11-21       Impact factor: 3.412

Review 8.  Polycystic ovary syndrome: current status and future perspective.

Authors:  Erin K Barthelmess; Rajesh K Naz
Journal:  Front Biosci (Elite Ed)       Date:  2014-01-01

9.  Multiple approaches for individualized fertility protective therapy in cancer patients.

Authors:  I Demeestere; F Moffa; F Peccatori; C Poirot; E Shalom-Paz
Journal:  Obstet Gynecol Int       Date:  2011-12-29

10.  Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles.

Authors:  Min Hye Choi; Sun Hee Lee; Hye Ok Kim; Sun Hwa Cha; Jin Young Kim; Kwang Moon Yang; In Ok Song; Mi Kyoung Koong; Inn Soo Kang; Chan Woo Park
Journal:  Clin Exp Reprod Med       Date:  2012-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.